Advanced Protein Technologies and Drug Development

Bridging the gap of technological advances in life sciences between China and the world

OPDIVO (nivolumab)

Product No.

LTE004

Synonyms:

Opdivo, ONO-4538, BMS-936558, MDX1106

Target:

PD-1

Description:

Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal junction (GEJ) cancer. It is used by slow injection into a vein.

Source:

CHO

Purity:

Greater than 98% by SDS-PAGE gel and HPLC analyses.

Bioactivity: